Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants

Medicine
Jinmiao LuZhiping Li

Abstract

Paracetamol (acetaminophen) has been proposed as an alternative medication for closing hemodynamically significant patent ductus arteriosus (PDA). However, the clinical outcomes remain inconclusive in very low birth weight (VLBW) and extremely low birth weight (ELBW) infants.The aim of this study was to compare the efficacy and safety of oral paracetamol and ibuprofen for pharmacological closure of PDA in premature infants from a real-world study.This retrospective study enrolled 255 preterm infants with birthweights of ≤1.5 kg, and echocardiographically confirmed significant PDA. Subjects were classified into 3 groups: Group I (standard-dose ibuprofen group) received 10 mg/kg oral ibuprofen followed by 5 mg/kg/day for 2 days. Group II (high-dose ibuprofen group) received 10 mg/kg/day oral ibuprofen for 3 days. Group III (paracetamol group) received 15 mg/kg/6 h oral paracetamol for 3 days.On day 9 after medication start, PDA closure was achieved in 61 (71.7%) patients assigned to the high-dose ibuprofen group, (63.8%) in the standard-dose ibuprofen group, and 33 (37.9%) of those in the oral paracetamol group (P <.001). Oral standard-dose ibuprofen was more effective than oral paracetamol (P = .001). The ductus closed faster in...Continue Reading

References

Dec 17, 1998·American Journal of Obstetrics and Gynecology·A M GuerguerianS Chemtob
Sep 19, 2003·The New England Journal of Medicine·Gregory L KearnsRalph E Kauffman
Feb 18, 2005·European Journal of Pediatrics·Ronald L ThomasJacob V Aranda
Oct 24, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·Patrick J McNamara, Arvind Sehgal
Dec 8, 2011·Archives of Disease in Childhood. Fetal and Neonatal Edition·Omer ErdeveNurdan Uras
May 24, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·E NadirM Feldman
May 20, 2016·Medicine·Nicolai NistorVioleta Streanga
Jun 30, 2016·British Journal of Clinical Pharmacology·Michael Rieder, Daniel Hawcutt
Apr 11, 2017·American Journal of Perinatology·Mehmet Yekta OncelSerife Suna Oguz
Jun 16, 2017·Archives of Disease in Childhood. Fetal and Neonatal Edition·Anke RaaijmakersKarel Allegaert
Jul 20, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Xintao HuangKai Wang
Oct 19, 2017·Pediatric Cardiology·Pramod PharandeArvind Sehgal
Nov 25, 2017·The Hastings Center Report·Jason L Schwartz
Dec 15, 2017·The Journal of International Medical Research·Manar Al-LawamaEman Badran
Jan 27, 2018·European Journal of Pediatrics·Carlo DaniSimone Pratesi
May 13, 2018·The Journal of Pediatrics·Elizabeth J ThompsonChristoph P Hornik
Jun 26, 2018·Expert Opinion on Drug Metabolism & Toxicology·Laura CuzzolinVassilios Fanos
Aug 15, 2018·American Journal of Law & Medicine·Joan H Krause, Richard S Saver
Oct 17, 2018·Journal of Perinatology : Official Journal of the California Perinatal Association·Martin KluckowNick Evans

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.